An Open-Label, Global, Phase (Ph) 1B/2 Study Adding Navtemadlin (Nvtm) To Ruxolitinib (Rux) In Patients (Pts) With Primary Or Secondary Myelofibrosis (Mf) Who Have A Suboptimal Response To Rux
Navtemadlin;Ruxolitinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: An Open-Label, Global, Phase (Ph) 1B/2 Study Adding Navtemadlin (Nvtm) To Ruxolitinib (Rux) In Patients (Pts) With Primary Or Secondary Myelofibrosis (Mf) Who Have A Suboptimal Response To Rux ### Output: Navtemadlin;Ruxolitinib